Key Insights• The Saudi Arabian bioceramics market operates within a healthcare environment defined by a relatively young but rapidly aging population, the transformative impact of Vision 2030 on healthcare infrastructure, and the presence of the Saudi Orthopaedic Association's Arthroplasty Registry. According to the General Authority for Statistics (GASTAT), the population aged 60 years and over reached approximately 1.7 million in 2025, accounting for 4.8% of the total population. A nationwide crosssectional study published in 2025 estimated the weighted prevalence of hip osteoarthritis (HOA) among Saudi adults at 1.26%, or roughly 1 in 80 adults. Key risk factors for HOA included age ≥60 years (odds ratio [OR] = 5.8), obesity (OR = 2.5), prior hip injury (OR = 4.1), and physical inactivity (OR = 1.9). Among patients with HOA, 78% reported chronic pain, and their average EQ5D health index (0.61 ± 0.20) was significantly lower than that of nonOA individuals (0.88 ± 0.15), reflecting substantial qualityoflife impairment. One in ten older individuals in Saudi Arabia suffers from knee osteoarthritis.• Saudi Arabia's healthcare delivery model for Bioceramics devices is being fundamentally reshaped by Vision 2030, the Kingdom's strategic framework for economic and social transformation.

The healthcare sector received SAR 180 billion in 2024, with a significant portion allocated for upgrading orthopedic care and increasing access to advanced surgical technologies. Under Vision 2030, the government is promoting investment in the medical sector, leading to increased adoption of orthopedic devices across public hospitals. King Saud Medical City has launched roboticassisted joint replacement services as part of the Health Transformation Program's goals under Vision 2030, enabling total and partial knee replacements as well as precise hip joint replacements requiring highlevel planning. The Saudi Orthopaedic Association (SOA) maintains an Arthroplasty Registry, though its current status appears to be inactive or not fully operational.• Regulatory oversight for medical devices in Saudi Arabia is administered by the Saudi Food and Drug Authority (SFDA) under the Law of Medical Devices issued by Royal Decree No. (M/54). No medical devices shall be circulated in the Kingdom unless they are registered and have obtained valid marketing authorization from the SFDA. The SFDA has established the Medical Device Establishment License (MDEL), a compulsory license that permits local companies to import, distribute, or manufacture medical devices in Saudi Arabia.

The SFDA has also issued updated requirements for licensing medical device establishments, effective January 15, 2025, which specify the licensing requirements and obligations for medical device establishments subject to the Law of Medical Devices and its Executive Regulations. The Saudi bioceramics market is supplied primarily through international manufacturers such as Zimmer Biomet, Stryker, DePuy Synthes, Smith & Nephew, CeramTec, Straumann, and Dentsply Sirona. In a significant development, aljeel Medical has partnered as a distributor for DePuy Synthes by Johnson & Johnson in Saudi Arabia, covering joint reconstruction, trauma, craniomaxillofacial, spinal surgery, and sports medicine.Market Outlook• According to the research report, "Saudi Arabia Bioceramics Market Outlook, 2031," published by Actual Market Research, the Saudi Arabia Bioceramics Market is anticipated to add to more than 19.15 Million by 2026-31.• A defining characteristic of Saudi Arabia's bioceramics market is the convergence of Vision 2030driven healthcare modernization with a growing demand for joint replacement procedures driven by demographic aging and lifestylerelated risk factors. Saudi Arabia's elderly population, while still a relatively small proportion of the total, is growing and increasingly requiring joint replacement procedures. However, despite frequent healthcare engagement among HOA patients50% consulted a physician in the past yearonly 22% considered surgery, and merely 10% underwent total hip replacement. This low surgical conversion rate, potentially due to limited access, awareness, or reluctance to pursue surgery, highlights the significant growth potential for joint replacement procedures and Bioceramics components.

The findings support national public health efforts aligned with Vision 2030 to enhance quality of life and chronic disease management.• The market also reflects Saudi Arabia's position as the largest healthcare market in the Gulf region, with significant government investment in medical infrastructure. The Kingdom allocated SAR 180 billion to healthcare in 2024, with SAR 20 billion specifically aimed at medical infrastructure upgrades and device procurement, including orthopedic devices. The adoption of roboticassisted joint replacement surgery at King Saud Medical City represents a significant advancement in surgical precision, enabling total and partial knee replacements as well as precise hip joint replacements. The aljeel Medical and DePuy Synthes partnership is expected to grow the orthopedics solutions business in Saudi Arabia across joint reconstruction, trauma, and spinal surgery.• The dental bioceramics sector in Saudi Arabia is experiencing substantial growth, driven by rising disposable incomes, increasing awareness of oral health, and the expansion of the middle class. Zirconiabased dental materials are emerging as a preferred alternative to traditional materials due to their superior aesthetics and biocompatibility. The Saudi dental implants market includes zirconia as a key material segment.

The growing emphasis on aesthetic, metalfree ceramic solutions in dental restorations and implants is creating significant opportunities for zirconiabased bioceramics.• The presence of the Saudi Orthopaedic Association's Arthroplasty Registry, while currently not fully operational, represents a foundational step toward systematic implant surveillance. The eventual activation and expansion of this registry would enable systematic monitoring of Bioceramics implant performance, track revision rates, and provide early warnings of device failures, supporting evidencebased clinical decisionmaking and strengthening patient safety.Market DynamicsDriver: Vision 2030 healthcare transformation and government investment in orthopedic infrastructureSaudi Arabia's bioceramics market is fundamentally driven by the Kingdom's strategic healthcare transformation under Vision 2030. The healthcare sector received SAR 180 billion in 2024, with SAR 20 billion specifically allocated for medical infrastructure upgrades and device procurement, including orthopedic devices. This substantial government investment is expanding access to advanced surgical technologies across public hospitals. The launch of roboticassisted joint replacement services at King Saud Medical City represents a significant advancement in surgical precision. The growing volume of joint replacement procedures, driven by the rising prevalence of osteoarthritiswith hip OA prevalence of 1.26% and one in ten older individuals affected by knee OAcreates sustained demand for durable, wearresistant Bioceramics components such as ceramic femoral heads and acetabular liners.Challenge: Low surgical conversion rates and the inactive status of the national arthroplasty registryOne of the principal challenges facing Saudi Arabia's bioceramics market is the significant gap between the prevalence of osteoarthritis and the rate of surgical intervention.

Among patients with HOA, only 22% considered surgery, and merely 10% underwent total hip replacement, despite 50% consulting a physician in the past year. This low surgical conversion rate, potentially due to limited access, awareness, or reluctance to pursue surgery, limits the volume of joint replacement procedures. Furthermore, while the Saudi Orthopaedic Association maintains an Arthroplasty Registry, its current status appears to be inactive or not fully operational. The absence of a comprehensive, active national arthroplasty registry limits the ability to systematically monitor implant performance, track revision rates, and provide early warnings of device failures. This fragmented surveillance infrastructure also constrains evidencebased clinical decisionmaking for implant selection.Trend: Rapid adoption of roboticassisted surgery and personalized joint replacement technologiesSaudi Arabia is experiencing a significant shift toward technologically advanced orthopedic care, supported by Vision 2030's healthcare transformation goals. King Saud Medical City has launched roboticassisted joint replacement services, enabling total and partial knee replacements as well as precise hip joint replacements requiring highlevel planning.

The first procedures were performed on patients, including a woman and a young woman in her twenties. Dr. Mohammad Alfagih Hospital has introduced personalized joint technology in knee replacement surgeries using 3D technology, described as the first and only in the Kingdom and the Gulf. The hospital also offers hip joint replacement surgery using the latest techniques with an anterior approach and a musclepreserving method, without cutting tendons or muscles. This trend toward roboticassisted and personalized surgical solutions is expected to drive demand for advanced Bioceramics components compatible with these technologies.Policies• SFDA Medical Device Registration and Law of Medical Devices (Royal Decree No. M/54): All implantable Bioceramics medical devices must obtain valid marketing authorization from the Saudi Food and Drug Authority (SFDA) before they can be circulated in the Kingdom.

The Law of Medical Devices, issued by Royal Decree No. (M/54), establishes the regulatory framework for medical devices.• Medical Device Establishment License (MDEL): The SFDA issues the Medical Device Establishment License (MDEL), a compulsory license that permits local companies to import, distribute, or manufacture medical devices in Saudi Arabia. The license is valid for one year and should be renewed yearly.• SFDA MDSREQ 9: Licensing Requirements for Medical Device Establishments: The SFDA has issued updated requirements for licensing medical device establishments, effective January 15, 2025, which specify the licensing requirements and obligations for medical device establishments subject to the Law of Medical Devices and its Executive Regulations. All establishments engaged in medical device activities must be registered and obtain a license.• SFDA Quality Management System and ISO 13485 Compliance: The SFDA has adopted a system to verify the quality, effectiveness, and safety of medical devices at all stages in their life cycle in accordance with the latest version of ISO 13485. The SFDA updated MDSREQ 10 on Quality Management Systems, effective January 27, 2025, restructuring the document and clarifying roles and responsibilities.• Saudi Orthopaedic Association Arthroplasty Registry: The Saudi Orthopaedic Association maintains an Arthroplasty Registry, though its current status appears to be inactive. The activation and expansion of this registry would enable systematic monitoring of implant performance and support evidencebased clinical decisionmaking.Segment AnalysisSaudi Arabia Bioceramics Market By Type• Bioinert Ceramics represents the largest product category in Saudi Arabia, driven by the growing volume of joint replacement procedures and the rapid adoption of roboticassisted surgical technologies. Bioinert ceramics maintain their physical integrity in the body and are ideal for loadbearing applications.

Alumina and zirconia femoral heads are critical components in hip replacements, with the prevalence of HOA at 1.26% and one in ten older individuals affected by knee OA. The Vision 2030driven expansion of orthopedic services and the adoption of roboticassisted surgery are expected to drive demand for durable bioinert ceramic components. In dental applications, bioinert zirconia is increasingly preferred for implants and restorations.• Bioactive Ceramics maintains an important position in Saudi Arabia, particularly in applications requiring bone bonding, including hydroxyapatite coatings, bioactive glass, and bone graft substitutes. These materials are used to promote osseointegration in both orthopedic and dental surgeries. The high prevalence of osteoarthritis and the growing volume of joint replacement procedures drive demand for bioactive materials.• Bioresorbable Ceramics represents a growing segment in Saudi Arabia, driven by increasing demand for temporary implants, bone void fillers, and drug delivery systems. These materials gradually dissolve and are replaced by natural bone, making them valuable in applications where permanent implants are unnecessary.Saudi Arabia Bioceramics Market By Material• Zirconia represents a leading material category in Saudi Arabia, driven by the country's growing dental implant market and emerging orthopedic applications.

Zirconia's superior fracture toughness and aesthetic translucency make it the preferred material for dental implants and restorations. The growing emphasis on aesthetics in dental care and the expansion of the middle class are driving zirconia adoption. The Saudi dental implants market includes zirconia as a key material segment.• Alumina maintains an important position in Saudi Arabian orthopedics, with alumina ceramic heads widely used in hip replacements. The prevalence of HOA at 1.26% and the Vision 2030driven expansion of orthopedic services support consistent demand for alumina components. Alumina's high hardness and wear resistance make it suitable for loadbearing orthopedic applications.• Calcium Phosphate is a critical material category encompassing hydroxyapatite and βtricalcium phosphate for bone graft substitutes and implant coatings. These materials are chemically analogous to the inorganic mineral phase of human bone and are widely used in orthopedic and dental bone regeneration applications.

The high prevalence of osteoarthritis and the growing volume of joint replacement procedures drive demand for calcium phosphatebased bone graft materials.• Calcium Sulfate holds a niche position in the Saudi Arabian market, primarily used as a synthetic bone void filler and antibioticeluting carrier for the treatment of osteomyelitis and infected surgical sites.• Others (Carbonbased Ceramic, Bioactive Glass) includes carbonbased ceramics for cardiovascular applications, bioactive glass for bone regeneration, and emerging Bioceramics materials.Saudi Arabia Bioceramics Market By Application• Orthopedics represents the largest application segment in Saudi Arabia, driven by the substantial burden of osteoarthritis and the Vision 2030driven expansion of orthopedic services. Hip OA prevalence is estimated at 1.26%, and one in ten older individuals suffers from knee OA. Orthopedic applications include ceramic femoral heads, ceramic knee components, calcium phosphate bone grafts, and hydroxyapatite coatings. The adoption of roboticassisted joint replacement surgery at King Saud Medical City and personalized joint technology using 3D technology are driving demand for advanced ceramic components.• Dental represents the secondlargest application segment, driven by the growing demand for aesthetic dental restorations and implants. Zirconia has emerged as the preferred material for implants, crowns, and bridges. The growing emphasis on aesthetics in dental care, rising disposable incomes, and the expanding middle class are driving demand for zirconiabased dental bioceramics.• Biomedical & Others encompasses tissue engineering scaffolds, drug delivery systems, cardiovascular applications, surgical instruments, and wound healing products.

Saudi research institutions continue to investigate novel Bioceramics materials for emerging biomedical applications.Major Bioceramics Manufacturers Operating in Saudi Arabia• International players with significant presence include Zimmer Biomet, Stryker, DePuy Synthes, Smith & Nephew, CeramTec, Straumann, and Dentsply Sirona. In a significant development, aljeel Medical has partnered as a distributor for DePuy Synthes by Johnson & Johnson in Saudi Arabia, covering joint reconstruction, trauma, craniomaxillofacial, spinal surgery, and sports medicine. These companies supply the Saudi market through distribution networks and authorized representatives, with foreign manufacturers required to obtain SFDA registration and licensing.• The Saudi market also benefits from the presence of specialized orthopedic centers such as Dr. Mohammad Alfagih Hospital, which offers personalized joint technology in knee replacement surgeries using 3D technology.Saudi Arabia Bioceramics Procedure Economics• Bioceramics implantation in Saudi Arabia operates within a mixed healthcare financing landscape comprising public healthcare facilities and private hospitals. The Saudi healthcare sector received SAR 180 billion in 2024, with significant investment in orthopedic care.• In private hospitals and specialized orthopedic centers, the total cost of joint replacement surgery including the ceramic component, hospital charges, surgeon fees, and postoperative management varies depending on hospital category, implant type, and geographic location. The adoption of roboticassisted surgery and personalized joint technology may influence implant selection and procedure costs.• In the dental sector, the cost of dental implants varies significantly depending on the material, manufacturer, and clinic location.

Zirconiabased implants are typically priced at a premium due to their superior aesthetics and biocompatibility.• Longterm costs include device monitoring, imaging surveillance, and revision procedures. The Saudi healthcare system's focus on quality improvement and patient safety supports highquality postoperative care.Saudi Arabia Bioceramics Market By End User• Hospitals and Surgical Centers dominate Bioceramics utilization in Saudi Arabia. The Kingdom's advanced healthcare infrastructure, including King Saud Medical City and other tertiary hospitals, performs the majority of joint replacement procedures. The adoption of roboticassisted joint replacement surgery and personalized joint technology is expanding in Saudi hospitals.• Dental Clinics and Laboratories represent a significant enduser category, driven by the growing demand for aesthetic dental restorations and implants. Dental clinics provide patientfacing implant and restorative services, while dental laboratories manufacture crowns, bridges, and custom abutments using CAD/CAM technology.• Others includes medical device manufacturers (OEMs), academic research institutions, and medical tourism facilitators. The Saudi healthcare sector's expansion under Vision 2030 is attracting international patients seeking advanced orthopedic and dental procedures.Saudi Arabia Bioceramics Market By Form• Liquid (Injectable) & Others represents a growing form segment in Saudi Arabia, driven by the increasing adoption of readytouse formulations including injectable bone cements, premixed calcium phosphate pastes, flowable bone graft putties, and presintered dental blocks for CAD/CAM milling.

The adoption of digital dentistry technologies supports demand for presintered zirconia blocks and other readytouse forms.• Powder maintains an important position as raw material feedstock for OEM manufacturing, plasmaspray coating of metallic implants, and onsite mixing for bone graft applications. Powder forms are primarily purchased by medical device manufacturers and hospitals for custom preparation. The SFDA's regulatory framework requires imported powder materials to meet registration and quality standards.Market Outlook by Healthcare Spending and Infrastructure• Saudi Arabia's bioceramics market growth is linked to the Kingdom's position as the largest healthcare market in the Gulf region and its transformative Vision 2030 healthcare investments. The healthcare sector received SAR 180 billion in 2024, with SAR 20 billion specifically allocated for medical infrastructure upgrades and device procurement. The elderly population reached 1.7 million in 2025, accounting for 4.8% of the total population.• The future growth opportunity for bioceramics in Saudi Arabia depends on several factors: the continued implementation of Vision 2030 healthcare transformation goals, the activation and expansion of the Saudi Orthopaedic Association's Arthroplasty Registry, the expansion of roboticassisted and personalized joint replacement services, and the growing demand for aesthetic dental restorations. The Saudi dental implants market includes zirconia as a key material segment.• Professional organizations including the Saudi Orthopaedic Association (SOA) and the Saudi Dental Association continue to advance the field through clinical research, guideline development, and professional education.

The SOA's Arthroplasty Registry, while currently not fully operational, represents a foundational step toward systematic implant surveillance. The Saudi Food and Drug Authority's regulatory framework, anchored by the Law of Medical Devices and updated licensing requirements, ensures that Bioceramics devices meet stringent safety and performance criteria. The Ministry of Health continues to conduct epidemiological surveillance of osteoarthritis and joint replacement procedures, informing healthcare planning and resource allocation for joint replacement services. The Kingdom's strategic focus on healthcare modernization under Vision 2030 positions Saudi Arabia as a rapidly emerging market for Bioceramics technologies in the Middle East.Considered in this report• Historic Year: 2020• Base year: 2025• Estimated year: 2026• Forecast year: 2031Aspects covered in this report• Bioceramics Market with its value and forecast along with its segments• Various drivers and challenges• On-going trends and developments• Top profiled companies• Strategic recommendationBy Type• Bioinert Ceramics• Bioactive Ceramics• Bioresorbable CeramicsBy Material• Alumina• Zirconia• Calcium Phosphate• Calcium Sulfate• Others (carbon-based ceramic, Bio activated Glass)By Application• Orthopedics• Dental• Biomedical & othersBy End User• Hospitals and Surgical Centers• Dental Clinics and Laboratories• OthersBy Form• Powder• Liquid (Injectable) & Others.